Table 4.
Variables | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|
HR | 95% CI | p-value | HR | 95% CI | p-value | |
Age at Surgery | 0.003 | 0.011 | ||||
≤16 | 5.933 | 1.8492–19.108 | 5.136 | 1.576–16.731 | ||
17-40 | 2.483 | 0.876–7.058 | 2.169 | 0.759–6.204 | ||
≥41 | Reference | Reference | ||||
Sex | 1.317 | 0.744–2.334 | 0.342 | |||
Family history | 0.653 | 0.090–4.740 | 0.850 | |||
Previous appendectomy | 1.068 | 0.500–2.280 | 0.864 | |||
Diagnosis by initial surgery | 1.716 | 0.723–4.074 | 0.215 | |||
Disease location at surgery | 0.009 | 0.023 | ||||
Ileum | Reference | Reference | ||||
Colon* | 2.173 | 1.196–3.951 | 2.011 | 1.102–3.670 | ||
Disease behavior at surgery | ||||||
Non-stricturing, non-penetrating | 0.381 | 0.118–1.225 | 0.092 | |||
Stricturing† | 0.793 | 0.419–1.501 | 0.475 | |||
Penetrating‡ | 2.019 | 1.009–4.041 | 0.042 | 0.131 | ||
Perianal disease at surgery | 2.017 | 1.137–3.576 | 0.014 | 2.239 | 1.236–4.059 | 0.008 |
Current smoking at surgery | 1.290 | 0.509–3.268 | 0.589 | |||
Emergent surgery | 0.954 | 0.501–1.817 | 0.885 | |||
Preoperative Medication | ||||||
5-ASA | 1.015 | 0.528–1.953 | 0.964 | |||
Corticosteroid | 0.785 | 0.450–1.371 | 0.393 | |||
Thiopurine | 1.191 | 0.674–2.105 | 0.546 | |||
Anti-TNF | 0.852 | 0.399–1.820 | 0.679 | |||
Postoperative Medication | ||||||
5-ASA | 0.497 | 0.221–1.116 | 0.083 | |||
Corticosteroid | 1.092 | 0.613–1.943 | 0.765 | |||
Thiopurine | 0.496 | 0.280–0.878 | 0.014 | 0.393 | 0.218–0.710 | 0.002 |
Anti-TNF | 0.698 | 0.378–1.290 | 0.025 |
HR, hazard ratio; CI, confidence interval; ASA, aminosalicylic acid; TNF, tumor necrosis factor.
Colonic involvement, including L2 (colonic) and L3 (ileocolonic); †Stricturing behavior, including the B2 (stricturing) and B2+B3 (stricturing and penetrating) phenotypes; ‡Penetrating behavior, including the B3 (penetrating) and B2+B3 (stricturing and penetrating) phenotypes.